Xtx Topco LTD Achilles Therapeutics PLC Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.75 - $1.25 $27,330 - $45,551
36,441 Added 239.44%
51,660 $42,000
Q1 2024

May 13, 2024
BUY
$0.82 - $1.57 $12,479 - $23,893
15,219 New
15,219 $19,000
Q3 2023

Nov 13, 2023
BUY
$0.84 - $1.11 $17,710 - $23,403
21,084 New
21,084 $19,000

Others Institutions Holding ACHL

# of Institutions
24
Shares Held
24.3M
Call Options Held
0
Put Options Held
0
View Full List

About Achilles Therapeutics plc

ACHL Quotes by TradingView
  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $47.3M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email